首页> 美国卫生研究院文献>Cancer Research and Treatment : Official Journal of Korean Cancer Association >Diagnostic Significance of p38 Isoforms (p38α p38β p38γ p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same
【2h】

Diagnostic Significance of p38 Isoforms (p38α p38β p38γ p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same

机译:p38亚型(p38αp38βp38γp38δ)在头颈部鳞状细胞癌中的诊断意义:血清水平比较评价和靶向该肽的新型肽抑制剂的设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeThe p38 mitogen-activated protein kinase (MAPKs) play a crucial role in the production of pro-inflammatory cytokines and over-expression of it increase cytokines which promote cancer. Among four isoforms, p38α has been well studied in head and neck squamous cell carcinoma (HNSCC) and other cancers as a therapeutic target. p38δ has recently emerged as a potential disease-specific drug target. Elevated serum p38α level in HNSCC was reported earlier from our lab. This study aims to estimate the levels of p38 MAPK-isoforms in the serum of HNSCC and design peptide inhibitor targeting the same.
机译:目的p38丝裂原活化蛋白激酶(MAPK)在促炎性细胞因子的产生中起关键作用,其过表达会增加促进癌症的细胞因子。在四种同工型中,p38α已在头颈鳞状细胞癌(HNSCC)和其他癌症中作为治疗靶点进行了深入研究。 p38δ最近已成为潜在的疾病特异性药物靶标。我们实验室早些时候报道了HNSCC中血清p38α水平升高。这项研究旨在评估HNSCC血清中p38 MAPK异构体的水平,并设计针对该多肽的肽抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号